IQVIA

Lilly’s Foundayo Reaches 1,390 Patients in First Week, Trailing Novo’s Oral Wegovy Launch

How AI Fits Into the Pharmaceutical Supply Chain

21CS Appoints Clemencia “Cleo” Clarke as Chief Commercial Officer to Drive Global Sales

Lilly CEO Sees Weight-Loss Drugs Reaching About Half of Potential Users at Peak

IQVIA (IQV) Launches IQVIA.ai Unified Agentic AI Platform with Nvidia

Hacker Group LAPSUS$ Claims Alleged AstraZeneca Data Breach

KERV.ai Receives Series B Funding From Coral Tree Partners, Fueling Next Phase of Growth in AI-Powered Contextual Commerce Media Solutions

Pharmaceutical Logistics in Demand as War Rattles Supply Chains

3 Trends Shaping the GLP-1 Landscape

SCIENTURE Announces Third Patent Grant for ARBLI™ (Losartan Potassium) Oral Suspension, Strengthening Long-Term Market Exclusivity Through 2041

82% of Radiologists and Other Physicians Now Employed by Corporate Entities

Gilead Price Target Raised to $175 From $171 at Morgan Stanley

From Free Rider to Innovator: How China Became a Global Pharmaceutical Powerhouse

Lilly’s Obesity Pill Foundayo Gets 1,390 Prescriptions in Debut Week

Supernus Pharmaceuticals Inc (SUPN) Q1 2026 Earnings Call Transcript

IQVIA (IQV) Launches IQVIA.ai Unified Agentic AI Platform with Nvidia

AVOXI Proactive Service SaaS Uses AI to Detect Voice Channel Issues Before Clients 97% of the Time

SpotSee-Controlant Collaboration Addresses Shipment Monitoring Gaps in Temperature-Sensitive Supply Chains

Cipla Secures FDA Approval for Generic Nintedanib Capsules, Expanding U.S. IPF Portfolio

Weekly TechBio News 🌟🎄

Claritas Rx Appoints New CRO and Promotes Two VPs to Accelerate Growth

Why Removing Humans From Care May Undermine Outcomes

FDA Requires Warning About Rare but Severe Itching After Stopping Long-Term Use of Oral Allergy Medicines Cetirizine or Levocetirizine (Zyrtec, Xyzal, and Other Trade Names)

Avenacy Announces Launch of Ready-to-Use Tranexamic Acid in 0.7% Sodium Chloride Injection in the U.S. Market

Labcorp, AWS and Datavant Launch AI‑Powered Platform to Speed Alzheimer’s Research

The Role of Class of Trade Research in Pharmaceutical Market Access

The Multi-Purpose Paradigm: Scaling AI ROI and De-Risking the Life Sciences Value Chain

Lupin Secures FDA Approval for Generic Glycerol Phenylbutyrate Oral Liquid for UCDs

The FDA Real Time Clinical Trial Announcement Quietly Dissolves Phase Gates, Breaks Biotech Capital Markets Plumbing, and Opens a Founder Sized Hole in Trial Infrastructure, Financing, and Workflow

NBCUniversal Leans Into Legacy Media Status, Pushes Performance at Upfront

Biogen Price Target Raised to $200 From $190 at Morgan Stanley

Omada Receives Dual Recognition as Leader and Emerging Innovator in QKS Group’s SPARK Matrix™ for Identity Governance & Administration (IGA)

Gilead to Acquire Germany's Tubulis for Up to $5 B, Boosting ADC Portfolio

Lilly Falls on Slower Start for Foundayo versus Wegovy

Otsuka Preps for July Decision on Centanafadine for ADHD

Biocon Gets Karthik SM as Head HR-India, Malaysia, Emerging Markets

Decision Criteria for Technology Commercialization of Medical Devices in 2026

Gilead’s Yeztugo Sees 9,000 Q1 Prescriptions Yet Faces Insurance Hurdles

Wegovy Pill Shows Strong Early Uptake, as Rival Looms

Bruno Vision Care Wins 2026 MedTech Breakthrough Award

IQVIA Signs Agreement to Acquire Drug Discovery Assets From Charles River Laboratories, Expanding End-to-End Drug Discovery Capabilities

Gas-O-Fast Ropes in Rakesh Bedi for New Ad Campaign

What the Six Hundred Billion Dollar MFN Headline Misses: The Best Price Carveout, the IQVIA Net Price Hole, and the CMMI BALANCE Workaround That Makes Trump’s Drug Pricing Framework Run

Rezolute Inc (RZLT) Q3 2026 Earnings Call Transcript

Syngene International Names Abhijit Zutshi as Chief Commercial Officer to Drive Global CRO Growth

Treatment Delays, Denials More Common in Prescriptions Initially Rejected

The Strategic Transformation of UK Primary Care Digital Infrastructure: TPG’s Acquisition of EMIS and the 2026–2028 Industry Outlook

Q&A: How RWE Is Reshaping Specialty Pharma Market Access

Roche Claims Midstage Win for Obesity Injectable

An ‘AI Scientist’ Can Tackle Drug R&D. What Does that Mean for Pharma?